IL‐8 gene polymorphisms (−251, +353, +781) were related to cancer susceptibility, especially −251 site and gastric cancer, suggesting these polymorphisms may offer value as biomarkers suitable for use when early detecting cancer. This evidence concerns the gene CXCL8 and cancer.